Latest Advances

  • Condition: Hepatitis C Virus (HCV) in Decompensated Liver Cirrhosis
  • Journal: Internal medicine (Tokyo, Japan)
  • Treatment Used: Ledipasvir and Sofosbuvir
  • Number of Patients: 1
  • Published —
This case report describes a 76-year-old woman with hepatitis C virus (HCV) with decompensated liver cirrhosis treated with ledipasvir and sofosbuvir.
  • Condition: Patients with Chronic Hepatitis C Virus (HCV) Infection in Belgium
  • Journal: Acta gastro-enterologica Belgica
  • Treatment Used: Second-Generation Direct-Acting Antiviral (DAA) Regimens
  • Number of Patients: 405
  • Published —
This study described the comorbidities and concomitant medications in patients initiating treatment for hepatitis C virus (HCV) infection with direct-acting antiviral (DAA) regimens in Belgium.
  • Condition: Chronic Hepatitis C
  • Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
  • Treatment Used: Ledipasvir plus Sofosbuvir versus Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir
  • Number of Patients: 4352
  • Published —
In this study, researchers compared the outcomes of using of ledipasvir plus sofosbuvir versus ombitasvir/paritaprevir/ritonavir/dasabuvir for the treatment of chronic hepatitis C.
  • Condition: Hepatitis C Virus
  • Journal: Global heart
  • Treatment Used: Directly Acting Antiviral Treatment
  • Number of Patients: 400
  • Published —
The study researched the outcomes of directly acting antiviral treatment for treating hepatitis C virus.
  • Condition: Hepatitis C Patients with Advanced Chronic Kidney Disease
  • Journal: PloS one
  • Treatment Used: Sofosbuvir
  • Number of Patients: 1464
  • Published —
The aim of this study was to evaluate the effectiveness and safety of Sofosbuvir-based therapy without Ribavirin for hepatitis C infected patients with advanced chronic kidney disease (CKD).
  • Condition: Adolescents and Children with Chronic Hepatitis C (CHC)
  • Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
  • Treatment Used: Sofosbuvir-Based Regimens
  • Number of Patients: 0
  • Published —
This article discusses the use of sofosbuvir-based regimens in the treatment of adolescents and children with chronic hepatitis C (CHC).
  • Condition: Hepatocellular Carcinoma and Hypersplenism
  • Journal: Medicine
  • Treatment Used: Splenectomy before Hepatectomy
  • Number of Patients: 266
  • Published —
The study researched the outcomes of splenectomy before hepatectomy in patients with hepatocellular carcinoma and hypersplenism.
  • Condition: Chronic Hepatitis C in Liver Transplant Recipients
  • Journal: Revista do Instituto de Medicina Tropical de Sao Paulo
  • Treatment Used: Direct Acting Antivirals
  • Number of Patients: 84
  • Published —
This study evaluated the effectiveness of direct acting antivirals (DAAs) for the treatment of chronic hepatitis C (CHC) in liver transplant recipients.
  • Condition: Hepatitis Associated Aplastic Anemia (HAAA)
  • Journal: Cell transplantation
  • Treatment Used: Umbilical Cord-Derived Mesenchymal Stromal Cells (UC-MSCs) Infusion and Cyclosporine A (CsA)
  • Number of Patients: NULL
  • Published —
This article reviewed the case of a patient with severe hepatitis (inflammation of the liver tissue) associated aplastic anemia (condition that occurs when the body stops producing enough new blood cells; HAAA) treated with umbilical cord-derived mesenchymal stromal cells (cells found throughout the body tissues that are essential for producing and repairing structural such as cartilage, bone, and fat; UC-MSCs) infusion and cyclosporine A (CsA).
  • Condition: Mother's Breast Milk Odor
  • Journal: BMC pediatrics
  • Treatment Used: Pain from Hepatitis B Vaccine
  • Number of Patients: 90
  • Published —
This study tested the safety and efficacy of using mother's breast milk odor to reduce pain during the hepatitis B vaccine for preterm infants.
  • Condition: Patients in Switzerland with Chronic Hepatitis C Virus (HCV) Infection
  • Journal: Swiss medical weekly
  • Treatment Used: Glecaprevir/Pibrentasvir Therapy
  • Number of Patients: 109
  • Published —
This study evaluated the effectiveness and safety of glecaprevir/pibrentasvir therapy in patients in Switzerland with chronic hepatitis C virus (virus that causes inflammation of the liver; HCV) infection.
  • Condition: Thrombocytopenic Chronic Hepatitis C (CHC)Patients
  • Journal: BMC gastroenterology
  • Treatment Used: Direct-Acting Antiviral Agent (DAA) Therapy
  • Number of Patients: 104
  • Published —
This study examined the role of baseline (BL) thrombopoietin (TPO) in patients with chronic hepatitis C (CHC) receiving direct-acting antiviral agents (DAA).
Showing 1-12 of 932